4 articles about Mariana Oncology
Mariana Oncology Inc., a biotechnology company pioneering a new era of radiopharmaceutical innovation to treat cancers with high unmet need, announced the closing of an oversubscribed $175 million Series B financing co-led by Deep Track Capital and Forbion.
Forbion co-leads $175 million Series B financing of Mariana Oncology as first investment of Forbion Ventures Fund VI
Forbion, a leading European life sciences venture capital firm, announces that it has co-led, together with Deep Track Capital, an oversubscribed $175 million Series B financing in Mariana Oncology, the first investment by its Forbion Ventures Fund VI.
Mariana Oncology Expands Management Team, Appoints Linda Bain Chief Operating Officer and Chief Financial Officer
Mariana Oncology today announced the appointment of Linda Bain as Chief Operating Officer and Chief Financial Officer.
BioSpace is proud to present its NextGen Bio “Class of 2023,” a list of the hottest recently launched life sciences companies in North America.